Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of albendazole in the preparation of medicines for treating glioblastoma

A glioblastoma, albendazole technology, applied in antitumor drugs, drug combinations, pharmaceutical formulations, etc., can solve the problem of high recurrence rate of glioblastoma, poor prognosis, difficult to completely remove glioblastoma tumor and other problems, to achieve the effect of inhibiting tumor cell growth, inhibiting tumor growth, and inhibiting vascular factors

Active Publication Date: 2019-02-15
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to provide the purposes of albendazole in the preparation of the medicine for treating glioblastoma, so as to solve the problem that it is difficult to completely remove glioblastoma through surgery, and the recurrence rate of glioblastoma is high and the prognosis is extremely poor. The problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of albendazole in the preparation of medicines for treating glioblastoma
  • Use of albendazole in the preparation of medicines for treating glioblastoma
  • Use of albendazole in the preparation of medicines for treating glioblastoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1: Validation of the effect of drugs containing albendazole on inhibiting the growth and proliferation of glioblastoma

[0039] Glioblastoma stem cells were cultured from the U87 cell line (purchased from Beijing Biobowell Biotechnology Co., Ltd.). U87 cells were cultured in serum free medium (SFM) at a planting density of 100,000 cells / ml. After subculture, the cells that became non-adherent and showed a neurosphere-like growth pattern were used as GSC cells. The composition of SFM is: DMEM / F12 (1:1), HEPES buffer (10mM), EGF (20ng / ml; Invitrogen), bFGF (20ng / ml; Invitrogen), L-glutamine (2mM), glucose ( 0.3% w / v), N-2 Additive (R&D Systems).

[0040] Culture of Glioma Cell Lines U87, U251, A172

[0041] Human glioma cells U87, U251, and A172 were obtained from the Neurosurgery Department of Xijing Hospital, Fourth Military Medical University (purchased from Beijing Biobowell Biotechnology Co., Ltd.), all in the presence of 10% fetal bovine serum, 100 U / ml p...

Embodiment 2

[0046] Example 2: Detection of cell apoptosis by flow cytometry

[0047] Digest and collect the cells treated with albendazole at each concentration for 24 h, adjust the cell concentration to 1×10 7 , take 100 μL each; after washing twice with Phosphate buffered solution (PBS), discard the supernatant; add 100 μL of pre-cooled binding buffer to resuspend the cells, put them in an ice bath; add 5 μL AnnexinⅤ-FITC and 5 μL PI In the cell suspension, mix gently; place the test tube at 4°C in the dark for 10 minutes; add 490 μL of binding buffer to suspend the cells, detect with flow cytometry, and analyze the percentage of cell apoptosis after medication. Repeat 3 times for each group. Such as Figure 6 as shown, Figure 6-1 For the control group, Figure 6-2 For the test group, after albendazole with a concentration of 100ng / ml acts on the glioblastoma cell line U251 cells, the results of the cell cycle are analyzed by flow cytometry. Albendazole makes the cells in the G1 ph...

Embodiment 3

[0048] Example 3: Validation of the effect of drugs containing albendazole on inhibiting the growth of glioblastoma in vivo

[0049] Xenograft tumor model in nude mice

[0050] Glioma stem cell GSC and cell line U87 cell suspension 0.2mL, containing 5×10 6 The cell viability was determined to be over 90% by trypan blue staining. Injected subcutaneously in the right armpit of nude mice. Measure the maximum long diameter (a) and the maximum short diameter (b) of the tumor with a vernier caliper every 3 days, according to the formula V=ab 2 / 2 to calculate the tumor volume.

[0051] In vivo administration of xenograft tumor in nude mice

[0052] The dosage of albendazole was set at 50, 100 mg / kg. Divide 30 tumor model nude mice into 6 groups (15 each for GSC and U87 models), 5 for each group, half male and half male, respectively GSC tumor model group, GSC albendazole 50 mg / kg group, GSC albendazole 50mg / kg group, GSC albendazole Dazol 100 mg / kg group, U87 tumor model group...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of albendazole in preparation of medicines for treating glioblastoma. The albendazole can be used for inhibiting the growth and proliferation of the glioblastoma, the medicine is an oral preparation or an injection, and the content of albendazole in the medicine is 25 to 100mg / kg. The application has the advantages that the in-vitro and in-vivo tests on the albendazole treating the glioblastoma proof and disclose that the function of the albendazole is realized by inhibiting blood vessels in the tumor, and the effect of inhibiting the cell growth of the glioblastoma is realized; proofed by the tests, the albendazole can be used for inhibiting the growth and wettability of the glioblastoma, and a new method for treating the glioblastoma is provided.

Description

【Technical field】 [0001] The invention belongs to the technical field of albendazole application, in particular to the application of albendazole in the preparation of medicines for treating glioblastoma. 【Background technique】 [0002] Malignant brain tumors include numerous classifications, the common ones are astrocytoma, oligodendroglioma, oligoastrocytoma, ependymoma, medulloblastoma, etc. Glioblastoma is the most common primary brain tumor in adults, and medulloblastoma is the most common brain tumor in children. Brain tumors can cause local or systemic symptoms due to their space-occupying properties. Systemic symptoms are mainly caused by increased intracranial pressure caused by tumors. Headaches may occur in many cases, and nausea, vomiting, and cranial nerve palsy (common sixth cranial nerve palsy) may also occur in severe cases. Local symptoms are mainly caused by space-occupying lesions of the tumor, which vary according to the location of the tumor, such as h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4184A61P35/00
CPCA61K31/4184
Inventor 毛星刚薛小燕章翔付洛安
Owner FOURTH MILITARY MEDICAL UNIVERSITY